Aclarion Inc
For the period ended Sep 30, 2024. Filed Nov 14, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Nov 14, 2024
ACON$1.60-8.6%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Statements of Cash Flows
| Nine Months Ended September 30, | ||
|---|---|---|
| 2024 | 2023 | |
| Cash flows from operating activities | ||
| Net income (loss) | $(5,003,355) | $(3,646,027) |
| Adjustments to reconcile net income (loss) to net cash used in operating activities: | ||
| Depreciation and amortization | 140,893 | 120,886 |
| Share-based compensation | 230,837 | 356,469 |
| Loss on exchange of debt | 1,073,317 | – |
| Loss on extinguishment of debt | 111,928 | – |
| Amortization of deferred issuance costs | 502,516 | 156,159 |
| Change in fair value related to warrants and derivative | (330,632) | (318,452) |
| Non-cash interest related to bridge funding | 58,002 | 48,954 |
| Change in assets and liabilities | ||
| Accounts receivable | (2,351) | (9,409) |
| Prepaids and other current assets | (329,306) | 34,182 |
| Accounts payable | (443,068) | 207,771 |
| Accrued and other liabilities | (326,399) | 103,695 |
| Note payable, net of discount | (31,129) | 32,607 |
| Net cash (used in) operations | (4,348,748) | (2,913,165) |
| Investing activities | ||
| Intangible assets - Patents | (261,220) | (85,603) |
| Net cash (used in) investing activities | (261,220) | (85,603) |
| Financing activities | ||
| Issuance of common stock and warrants related to public offering, net deductions | 2,691,391 | – |
| Proceeds from equity line | 1,754,032 | – |
| Proceeds from common stock and warrant RegA+ offering | 529,254 | – |
| Proceeds from sales of C-Series preferred stock and warrants | 1,000,000 | – |
| Repayment of promissory notes | (300,973) | – |
| Common stock cash issuance costs | (714,332) | – |
| Preferred stock cash issuance costs | (35,000) | – |
| Bridge fund cash issuance costs | (23,375) | (312,588) |
| Proceeds from bridge funding | – | 2,000,000 |
| Proceeds from sale of Series A preferred stock | – | 1,000 |
| Redemption of Series A Preferred stock | – | (1,000) |
| Net cash provided by financing activities | 4,900,996 | 1,687,412 |
| Net increase (decrease) in cash and cash equivalents | 291,028 | (1,311,356) |
| Cash, cash equivalents and restricted cash, beginning of period | 1,031,069 | 1,482,806 |
| Cash, cash equivalents and restricted cash, end of period | $1,322,098 | $171,450 |
| Non-cash activities | ||
| Dividends accrued on preferred shares | 12,142 | – |
| Exchange of indebtedness for preferred shares | 930,052 | – |
| Issuance of common shares in exchange for debt | 1,771,606 | – |
| Issuance of bridge fund commitment shares | 33,297 | – |
| Accrued issuance costs related to preferred stock | 55,000 | – |
| Accrued issuance costs related to common stock | 94,733 | – |
| Designation of prepaid expenses to common stock issuance costs | 919,439 | – |
| Issuance of common shares related to restricted stock units | 216,397 | – |
| Fair value of warrants and derivative related to bridge funding | – | 896,798 |
| Accrued debt issuance costs related to bridge funding | – | 16,225 |
| Issuance of warrants related to bridge funding | – | 60,000 |
| Issuance of commitment shares related to bridge funding | – | 175,619 |
| Original issue discount (15%) related to bridge funding | – | 300,000 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.